Generation and validation of the hTert-RPE1_WntRep_shRNA-BBS4 cell line used for RNAi screen. (A) hTert-RPE1 cell line was transfected with Wnt Reporter plasmid and selected with Geneticin (500 µg/ml) 48 hours post transfection. Eight cell colonies were picked and treated with Control-or Wnt3a-conditioned medium (CM), followed by luciferase assay. Graph represents the fold increase in comparison to Control-CM treatment and error bar indicates the standard deviation of triplicates. Clone 4 were selected for the further generation of BBS4-depleted cell line. (B) hTert-RPE1_WntRep cell were transduced with LKO-cont (SHC002) or LKO-BBS4 lentivirus, followed by puromycin selection (5 µg/ml). Three of control and six of BBS4-depleted cell clones were picked and subjected to Western blot for assessing the suppression of BBS4. HSP90 served as loading control. (C) LKO-control clone 1 and LKO-BBS4 clones 1, 2, 4 and 5 (clone 3 and 6 were dropped due to low viability) from (B) were subjected to Luciferase assay after 8 hours of conditioned media treatment. Graph represents the fold increase in comparison to Control-CM treatment of LKO-cont line and error bar indicates the standard deviation of triplicates. LKO-BBS4 clone 4 were selected for further RNAi screening.
Suppression of BBS4 enhances the expression of AXIN2. hTert RPE cells which stably express shRNA targeting BBS4 or non-silencing control were incubated with Wnt3a-conditioned media for 4 hours. The cells were then harvested followed by AXIN2 qPCR. Compared to the shRNA-control without Wnt3a stimulation, the mean relative expression level of AXIN2 from triplicated experiments is presented in the graph. Error bar: standard error of mean. Asterisk denotes the significance of AXIN2 expression (*: p< 0.05; **: p< 0.001; 2-tailed t test). Figure 3 Morpholino knock-down efficiency. Zebrafish embryos at 1-4 cell stage were injected with the morpholinos targeted to the genes indicated in the figure. 30 hours post of injection, 15 embryos were collected and subjected to RT-PCR for the expression of targeted genes. RT-PCR for β-actin were served as loading control. RT: Reverse Transcriptase.
Supplementary

Supplementary Figure 4 Assessment of the CE rescue by suppression of 13 candidate genes. (A)
zebrafish embryos were injected with bbs4-morpholino (bbs4-MO) plus either standard control morpholino (std) or the MO targeting to zic1, ptma, engase, dtx1, tex36, tdrd12, pitpnm2, c14orf166, entpd6 and enpp7. Depletion of bbs4 results in CE defects, including wider anterior-posterior body gap, somite (Class I) and loss of eyes (Class II) ($$$: p< 0.001 in comparison to control embryos). Co-injection of zic1-MO, ptma-MO, engase-MO, dtx1-MO, tex36-MO, tdrd12-MO, c14orf166-MO and entpd6-MO in bbs4 morphants reduces the percentage of both Class I and Class II embryos. (**: p< 0.01; ***: p< 0.001 in comparison to bbs4 morphant coinjected with std-MO, Chi-square). Co-injection of enpp7-MO increases the percentage of both Class I and Class II embryos significantly. (###: p< 0.001 in comparison to bbs4 morphant co-injected with std-MO). (B) Classification of the embryos with CE defects. CE-deficient embryos exhibit wider anterior-posterior body gap, somite (Class I) and delayed eye development (Class II). (C) bbs4 morphants were co-injected with gRNA/Cas9 of drd5 or pcf11. Co-injection of drd5-gRNA/Cas9 in bbs4 morphant ameliorates the CE defects (***: p< 0.001, Chi-square). 
